Seattle Flunks Vaccine Science

Nothing says First World city like Seattle does. Come for the cachet, stay for the Seahawks, and give a nod to the Starbucks and the Amazon and the mothership that is Microsoft just to the east. There’s nothing this so-hip-it-hurts town lacks, it seems—except perhaps for common sense. If you’re looking for that, the developing world is a far better bet. That’s the inescapable conclusion on what should be a very good week for public health—and childhood health in particular—with the World Health Organization and other groups announcing on July 24 that Nigeria has gone a full year without a single reported case of polio. Pending further certification, the country will be removed from the dwindling list of countries in which the disease is endemic, leaving just Pakistan and Afghanistan. If Nigeria’s caseload remains at zero for two more years, it will be officially declared polio free. How did the country that as recently as 1988 saw 30,000 children—a stadium’s worth—paralyzed or killed by polio every year achieve such a stunning turnaround? No surprise: vaccines—the same vaccines that have saved the lives and health of millions of children around the world, and the same vaccines that saw polio eradicated entirely in the U.S. in 1979. So it came as a head-slapping development that earlier this month, Seattle news outlets reported that polio vaccination rates in their city have hit a low of just 81.4%, or worse tha...
Source: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized anti-vaxxers Nigeria polio Seattle vaccines Source Type: news

Related Links:

Abstract DNA repair pathways are closely associated with the maintenance of genomic integrity, disease outbreak, and the development of therapeutics. Owing to these significances, novel analytical methods for enzymes that are involved in the DNA repair pathways have been actively investigated. This review focuses on discussions on nucleic acid-based methods, especially those based on the fluorescence, for the determination of DNA repair enzymes. Furthermore, this review not only provides meaningful insights in creating ingenious fluorescent detection methods but it also suggests future directions that will be foll...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
Condition:   Influenza Intervention:   Biological: Quadrivalent inactivated influenza vaccine (IIV) Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Multiple Sclerosis Interventions:   Drug: Bacille Calmette-Guerin vaccine;   Drug: Placebo Sponsor:   S. Andrea Hospital Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Hepatitis C, Chronic Interventions:   Drug: sofosbubir/velpatasvir;   Drug: sofosbubir/velpatasvir/voxilaprevir Sponsor:   Partners in Health Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   HPV-Related Cervical Carcinoma Intervention:   Behavioral: knowledge questioannaire Sponsor:   University Hospital, Geneva Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Human Papillomavirus Infection Intervention:   Other: VACs Sponsors:   University of North Carolina, Chapel Hill;   Centers for Disease Control and Prevention;   American Cancer Society, Inc.;   Wisconsin Department of Health and Family Services;   New York State Department of Health;   Association of Immunization Managers Recruiting
Source: - Category: Research Source Type: clinical trials
PLYMOUTH MEETING, Pa., March 25, 2019 -- (Healthcare Sales &Marketing Network) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the appointment of Dr. Ann C. Miller to its Board of Directors. Dr. Miller had an outstanding marketing career la... Biopharmaceuticals, Oncology, Personnel Inovio Pharmaceuticals, immunotherapy, cancer vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
Local Afghan Taliban leaders are hindering global efforts to end polio, but Afghanistan and Pakistan must continue their fight to "get to zero" cases, the philanthropist Bill Gates said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Climate change is in the news more and more, and the projections from virtually all of the world’s climate scientists are becoming increasingly dire. Almost daily, we are confronted with images of extreme weather patterns, disease outbreaks, and the loss of certain species. It is almost biblical in proportion. Most poignant, to me, are the distressing images of starving, displaced polar bears whose icy habitats are melting away. Many of the things that we can do to prevent or slow climate change are intuitive, difficult as they may be to put into practice: conserve energy, drive less, elect politicians that are dedic...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Environmental health Food as medicine Source Type: blogs
Kingston Pharma, LLC recalls Lot KL180157 of its 2-fluid ounce (59 mL) bottles of DG ™/health NATURALS baby Cough Syrup + Mucus” because it has the potential to be contaminated with Bacillus cereus/ Bacillus circulans.
Source: NCCAM Featured Content - Category: Complementary Medicine Authors: Source Type: news
More News: Accidents | Algeria Health | Child Development | Children | Cough | El Salvador Health | Endemics | Guyana Health | Health | International Medicine & Public Health | Kyrgyzstan Health | Measles | Measles Vaccine | Middle East Health | Mongolia Health | Mumps | Mumps Vaccine | Outbreaks | Pharmaceuticals | Polio | Polio Vaccine | Rubella | Rubella Vaccine | Rwanda Health | Science | Teaching | Toxicology | Universities & Medical Training | Vaccines | WHO | Whooping Cough | Whooping Cough (Pertussis) Vaccine | Yemen Health